Evidence map›Paper›PMID 15937162›Full record

ArticleJournal of bacteriology2005

Peculiar properties of DsbA in its export across the Escherichia coli cytoplasmic membrane.

Nobuyuki Shimohata, Yoshinori Akiyama, Koreaki Ito

Abstract read
In one paragraph

Article in Journal of bacteriology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Emerging themes in SecA2-mediated protein export.Nature reviews. Microbiology · 2012
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The bacterial twin-arginine translocation pathway.Annual review of microbiology · 2006
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nobuyuki ShimohataInstitute for Virus Research, Kyoto University, Kyoto 606-8507, Japan.
Yoshinori Akiyama
Koreaki Ito

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Export of DsbA, a protein disulfide bond-introducing enzyme, across the Escherichia coli cytoplasmic membrane was studied with special reference to the effects of various mutations affecting translocation factors. It was noted that both the internalized precursor retaining the signal peptide and the periplasmic mature product fold rapidly into a protease-resistant structure and they exhibited anomalies in sodium dodecyl sulfate-polyacrylamide gel electrophoresis in that the former migrated faster than the latter. The precursor, once accumulated, was not exported posttranslationally. DsbA export depended on the SecY translocon, the SecA ATPase, and Ffh (signal recognition particle), but not on SecB. SecY mutations, such as secY39 and secY205, that severely impair translocation of a number of secretory substrates by interfering with SecA actions only insignificantly impaired the DsbA export. In contrast, secY125, affecting a periplasmic domain and impairing a late step of translocation, exerted strong export inhibition of both classes of proteins. These results suggest that DsbA uses not only the signal recognition particle targeting pathway but also a special route of translocation through the translocon, which is hence suggested to actively discriminate pre-proteins.

Indexed as

Amino Acid SequenceCell MembraneEscherichia coliEscherichia coli ProteinsMolecular Sequence DataMutationProtein BiosynthesisProtein Disulfide-IsomerasesProtein PrecursorsProtein TransportSEC Translocation ChannelsSignal Recognition ParticleEscherichia coli ProteinsProtein Disulfide-IsomerasesProtein PrecursorsSEC Translocation ChannelsSecY protein, E coliSignal Recognition Particle

Identifiers

PMID15937162
PMCPMC1151732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.